Saturday 17 October 2026 Export YTENQ’s income statement to Excel — free account

Metabolix, Inc.

YTENQ Basic Materials Agricultural Inputs

Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022. Operating cash flow growth for three consecutive years.

0.00 0.00 NaN

Follow YTENQ

Alert me

Market cap: $1.5M
P/E: 0.0×
Fwd P/E: −0.1×
Dividend yield: —
F-score: 2/9
Altman Z: −161.45
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 12.77%

Capital & Financial Ratios $m

Market Cap 1.52

Revenue 0.90

Net Income (12.70)

Free Cash Flow (5.80)

Net Debt (0.73)

Current Ratio 0.16

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (0.12)

P/S ratio 0.00

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth 58.52%

Next Y EPS Growth (12.58%)

Next Y revenue growth 1,900.00%

Next 5Y EPS Growth 0.00%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

EV/Sales against its own 10 years 14.00%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2021	2022	2023	Q'24
Cash	16	4	1	1
Receivables	0	0	—	—
Inventory	—	—	—	—
Other	—	—	—	—
	17	5	1	1

	2021	2022	2023	Q'24
Payables	0	0	1	2
ST’ Debt	—	—	—	—
Other	—	—	—	—
	2	2	5	8

Compound Annual Growth %

	10y	5y	3y
Sales	(33.92%)	(35.94%)	(57.81%)
Cash Flow	0.00%	0.00%	0.00%
Earnings	0.00%	0.00%	0.00%
Book Value	0.00%	0.00%	0.00%

Revenue $m

	Jun	Sep	Dec	Year
’26	0	—	—	—
’23	—	—	—	0
’22	0	0	0	0
’21	0	0	0	1
’20	0	0	0	1
’19	0	0	0	1
’18	0	0	0	1

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(1)	(1)	—	—	—
’23	(3)	(3)	(3)	(2)	(10)
’22	(3)	(3)	(3)	(3)	(11)
’21	(3)	(2)	(2)	(2)	(9)
’20	(2)	(2)	(2)	(2)	(9)
’19	(2)	(2)	(1)	(3)	(9)
’18	(3)	(2)	(2)	(2)	(9)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(1)	(1)	—	—	—
’23	(3)	(3)	(3)	(2)	(10)
’22	(3)	(3)	(3)	(3)	(12)
’21	(3)	(2)	(2)	(3)	(9)
’20	(2)	(2)	(2)	(2)	(9)
’19	(2)	(2)	(1)	(3)	(9)
’18	(3)	(2)	(2)	(2)	(9)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(4.77)	(5.04)	—	—	—
’23	(18.22)	(15.35)	(9.83)	(6.47)	(43.64)
’22	(16.31)	(16.79)	(17.03)	(16.07)	(66.19)
’21	(14.39)	(15.35)	(11.75)	(14.63)	(55.87)
’20	(50.84)	(22.06)	(20.86)	(18.94)	(103.12)
’19	(211.03)	(143.88)	(153.48)	(349.49)	(851.32)
’18	(230.22)	(230.22)	(249.40)	(182.25)	(882.49)

Fiscal quarters ending in the months shown.

Group	Line	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e
Price, $
Price, $	Low	—	—	2,400.00	1,699.20	652.80	107.42	84.00	95.52	39.12	4.32	Analyst estimates 2024–2026 Powerpack
	High	—	—	21,983.99	8,928.00	2,976.00	1,696.90	352.56	563.76	173.04	100.56
People
People	Employees	—	—	20	20	22	25	25	29	30	29
	Revenue/emp, $m	—	—	0.06	0.05	0.03	0.03	0.03	0.02	0.02	0.00
Income, $m
Income, $m	Revenue	—	—	1	1	1	1	1	1	0	0
	Gross margin, %	—	—	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
	EBT	—	—	(10)	(9)	(9)	(13)	(10)	(11)	(13)	(14)
	EBT margin, %	—	—	(887.49)	(995.34)	(1,651.98)	(1,638.96)	(1,270.34)	(1,790.72)	(2,980.00)	(24,091.67)
	Net income	—	—	(8)	(9)	(9)	(13)	(10)	(11)	(14)	(14)
	Depreciation	—	—	1	0	0	0	0	0	0	0
Per share, $
Per share, $	Revenue	—	—	399.66	277.65	53.46	53.03	8.07	3.11	2.20	0.18
	Earnings	—	—	(2,589.93)	(3,155.87)	(882.49)	(851.32)	(103.12)	(55.87)	(66.19)	(43.64)
	Cash flow	—	—	(4,966.90)	(2,412.35)	(841.73)	(569.34)	(87.46)	(46.90)	(55.63)	(30.39)
	Capex	—	—	(259.31)	(1.76)	(4.04)	(4.01)	(0.67)	(0.96)	(0.75)	(0.14)
	Free cash flow	—	—	(5,226.21)	(2,414.12)	(845.77)	(573.36)	(88.13)	(47.86)	(56.38)	(30.53)
	Book value	—	—	2,196.21	3,971.18	547.88	(268.75)	96.28	81.23	21.46	(7.49)
	Shares, m	—	—	0	0	0	0	0	0	0	0
Valuation, ×
Valuation, ×	P/E	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/S	—	—	8.43	7.09	14.90	3.10	17.19	37.94	18.70	5.54
	P/B	—	—	1.53	0.53	1.45	0.00	1.44	1.45	1.91	0.00
	EV/Sales	—	—	3.10	(7.16)	14.64	(6.20)	9.00	16.22	13.65	5.27
	EV/FCF	—	—	(0.24)	0.79	(0.93)	0.57	(0.82)	(1.05)	(0.53)	(0.19)
Cash, $m
Cash, $m	Operating cash flow	—	—	(14)	(8)	(9)	(9)	(9)	(9)	(11)	(10)
	Capex	—	—	(1)	0	0	0	0	0	0	0
	Free cash flow	—	—	(15)	(8)	(9)	(9)	(9)	(9)	(12)	(10)
Balance, $m
Balance, $m	Working capital	—	—	5	13	5	9	9	15	3	(3)
	Total debt	—	—	1	—	6	4	3	3	2	—
	Net debt	—	—	(6)	(14)	(6)	(11)	(10)	(16)	(4)	(1)
	Shareholders’ equity	—	—	6	14	6	(4)	10	16	4	(2)
Returns, %
Returns, %	ROA	—	—	(54.63)	(78.34)	(61.56)	(87.31)	(65.34)	(63.15)	(95.20)	(241.08)
	ROIC	—	—	(3,335.94)	0.00	0.00	0.00	0.00	(20,298.61)	(15,862.03)	0.00
	ROE	—	—	(78.40)	(113.61)	(99.93)	(1,606.45)	(374.74)	(86.32)	(132.83)	(1,508.09)

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2023 · latest quarter Jun 2024

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
AVD American Vanguard Corporation	$36.9M	— (loss-making)	11.4×	−9.71% (below 0%: shrinking)	n/m	−33.18% (below 0%: shrinking)	29.73%	(0.26%)	Compare
LVROF Lavoro Limited	$34.8M	— (loss-making)	— (loss-making)	−23.62% (below 0%: shrinking)	n/m	−6.85% (below 0%: shrinking)	15.65%	0.67%	Compare
BIOX Bioceres Crop Solutions Corp.	$18.6M	— (loss-making)	27.0×	−34.73% (below 0%: shrinking)	n/m	+344.29% (above 0%: growing)	32.23%	(10.91%)	Compare
SEED Origin Agritech Limited	$8.9M	— (loss-making)	— (loss-making)	+432.86% (above 0%: growing)	n/m	−107.51% (below 0%: shrinking)	22.38%	0.00%	Compare
ENFY Enlightify Inc.	$1.8M	— (loss-making)	—	−16.73% (below 0%: shrinking)	n/m	+48.84% (above 0%: growing)	23.90%	8.21%	Compare
YTENQ Metabolix, Inc.	$1.5M	— (loss-making)	— (loss-making)	+305.41% (above 0%: growing)	n/m	+81.47% (above 0%: growing)	100.00%	(711.78%)
BHILQ Benson Hill, Inc.	$1.5M	— (loss-making)	— (loss-making)	+45.32% (above 0%: growing)	n/m	+56.10% (above 0%: growing)	(1.34%)	(57.94%)	Compare
NXTS Nexentis Technologies Inc.	$990.0K	0.0×	— (loss-making)	−4,244.44% (below 0%: shrinking)	n/m	−2.86% (below 0%: shrinking)	100.00%	502.68%	Compare
SANW S&W Seed Company	$760.0K	— (loss-making)	— (loss-making)	+1.97% (above 0%: growing)	n/m	+39.42% (above 0%: growing)	37.74%	(6.94%)	Compare
Median of peers	$5.4M	—	—	−13.22%	—	+18.28%	26.82%	(0.13%)

All 18 Agricultural Inputs stocks →

Metabolix, Inc. (YTENQ) key facts

Concern: Metabolix, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $60,000.00, down 86.7% from fiscal 2022.
Metabolix, Inc. (YTENQ) is an Agricultural Inputs company in the Basic Materials sector.
Return on equity was −1,508.1% and debt-to-equity 0.00.
Its Piotroski F-score is 2 out of 9 and its Altman Z-score is −161.45 (distress zone) for fiscal 2023.

Source: company filings (standardised) and stockrow calculations.